Highlights
A collection of news and information related to Plavix (drug) published by this site and its partners.
Displaying items 1-12 of 30
» View wsbtradio.com items only
1
2
3
Next >
-
French competition body fines Sanofi in Plavix dispute
ReutersPARIS (Reuters) - The French Competition Authority said on Tuesday it fined drugmaker Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to its blood thinner, Plavix. The decision...Tags: Drugs and Medicines, Clopidogrel (drug), Fines, Teva Pharmaceutical Industries Limited, Punishment
-
Shop around for deals on prescription drugs
If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...Tags: Prices, Target, Actos (drug), Pharmaceuticals, Asthma
-
RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
Reuters(Repeats to widen readership) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc...Tags: Prices, European Parliament, Novartis AG, Science and Technology, Consumers
-
U.S. spending on medicines fell for first time in 2012
Reuters(Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday. Overall U.S....Tags: Patents, Copyrights and Trademarks, Flu, Patient Protection and Affordable Care Act, AstraZeneca Plc, Bristol Myers Squibb Company
-
XxANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
ReutersBy Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown...Tags: European Parliament, Prices, Novartis AG, Science and Technology, Consumers
-
REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
Reuters(Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...Tags: Prices, European Parliament, Novartis AG, Science and Technology, Consumers
-
Spending on drugs falls for first time in 55 years
ReutersThe amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...Tags: Bristol Myers Squibb Company, Patents, Copyrights and Trademarks, Health Insurance Cost, Prescription Drugs, Lipitor (drug)
-
Drug spending falls for first time in 6 decades
An explosion of cheap generic substitutes for widely used prescription drugs last year helped drive the first decline in pharmaceutical spending in the U.S. in nearly six decades. Drug makers often lament what they call the patent cliff, which is when...
Tags: Patents, Copyrights and Trademarks, Flu, Science and Technology, Prescription Drugs, Pharmaceuticals
-
More people buying prescription drugs overseas online
Reporter and PhotographerThe federal government doesn't want you to do it but more and more of you are. The high cost of prescription drugs has many Americans turning to other countries to make their purchases. The Food and Drug Administration says that's dangerous. More...Tags: Food and Drug Administration, Prescription Drugs, Pharmaceuticals, Drugs and Medicines, Viagra (drug)
-
Patients settle stent claims against Midei, St. Joseph
Nearly 250 of the patients who accused cardiologist Dr. Mark Midei of performing unnecessary stent procedures at St. Joseph Medical Center settled their lawsuits against him Thursday, a major step forward in one of the largest medical malpractice cases in...
Tags: Cardiologists, Health and Medical Professionals, Laws, Baltimore County, Litigation
-
Strategies for cutting the cost of prescription drugs
When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...
Tags: Oncology, Science and Technology, Bevacizumab (drug), Pharmaceuticals, National Institutes of Health
-
Sinai to research new drug to prevent blood clots, heart attacks in stent patients
A Sinai Hospital cardiologist is launching a clinical trial of a type of coronary artery disease drug not yet tested in humans, building on a history at the Baltimore hospital of research to develop more effective treatments to prevent blood clotting....
Tags: University of Maryland, College Park, Cardiologists, Science and Technology, Food and Drug Administration, Pharmaceuticals
May 14, 2013
|Story| Reuters
May 12, 2013
|Story| Herald Mail
May 10, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 9, 2013
|Story| Los Angeles Times
May 7, 2013
|Story| KSPR-TV
May 2, 2013
|Story| Baltimore Sun
Apr 19, 2013
|Story| Los Angeles Times
Apr 26, 2013
|Story| Baltimore Sun
Original site for Plavix (drug) topic gallery.